• Mashup Score: 0

    Objective In the management of patients with IBD, there is a need to identify prognostic markers and druggable biological pathways to improve mucosal repair and probe the efficacy of tumour necrosis factor alpha biologics. Vnn1 is a pantetheinase that degrades pantetheine to pantothenate (vitamin B5, a precursor of coenzyme A (CoA) biosynthesis) and cysteamine. Vnn1 is overexpressed by inflamed…

    Tweet Tweets with this article
    • #GUTImage from the paper "Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis" via https://t.co/CI4hhv6pW6 #Colitis #SCFA @achillebro https://t.co/1XJg6a7XLd

  • Mashup Score: 0

    Objective In the management of patients with IBD, there is a need to identify prognostic markers and druggable biological pathways to improve mucosal repair and probe the efficacy of tumour necrosis factor alpha biologics. Vnn1 is a pantetheinase that degrades pantetheine to pantothenate (vitamin B5, a precursor of coenzyme A (CoA) biosynthesis) and cysteamine. Vnn1 is overexpressed by inflamed…

    Tweet Tweets with this article
    • #GUTImage from the paper "Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis" via https://t.co/CI4hhv6pW6 #Colitis #SCFA @achillebro https://t.co/6aOkmMowhp

  • Mashup Score: 2

    Objective In the management of patients with IBD, there is a need to identify prognostic markers and druggable biological pathways to improve mucosal repair and probe the efficacy of tumour necrosis factor alpha biologics. Vnn1 is a pantetheinase that degrades pantetheine to pantothenate (vitamin B5, a precursor of coenzyme A (CoA) biosynthesis) and cysteamine. Vnn1 is overexpressed by inflamed…

    Tweet Tweets with this article
    • #GUTImage from the paper "Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis" via https://t.co/CI4hhv6pW6 #Colitis #SCFA @achillebro https://t.co/BeeJlS3XBU

  • Mashup Score: 0

    Objective In the management of patients with IBD, there is a need to identify prognostic markers and druggable biological pathways to improve mucosal repair and probe the efficacy of tumour necrosis factor alpha biologics. Vnn1 is a pantetheinase that degrades pantetheine to pantothenate (vitamin B5, a precursor of coenzyme A (CoA) biosynthesis) and cysteamine. Vnn1 is overexpressed by inflamed…

    Tweet Tweets with this article
    • #GUTImage from the paper "Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis" via https://t.co/CI4hhv6pW6 #Colitis #SCFA @achillebro https://t.co/dXbV8jwDFx